Wakefield, Mass., April 25th, 2023- Myrtelle Inc., (“Myrtelle” or the “Company”), a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
WARRINGTON, Pa. , June 27, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics,
Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology
company focused on advancing late-stage interventions for cardiovascular
disorders, today announced that the Company appointed Mark Strobeck , Ph.D.